BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 4581992)

  • 61. [Oral antidiabetics today].
    Aro A
    Duodecim; 1981; 97(12):837-47. PubMed ID: 7297451
    [No Abstract]   [Full Text] [Related]  

  • 62. Efficacy and safety of oral hypoglycemic agents.
    Seltzer HS
    Annu Rev Med; 1980; 31():261-72. PubMed ID: 6994611
    [No Abstract]   [Full Text] [Related]  

  • 63. [Clinical experiences in long-term therapy of adult diabetes using glibornuride (Ro 6-4563)].
    Ewald W; Hartmann HM; Haupt E; Kunkel W; Neubauer M; Bartelt KM; Beyer J; Cordes U; Schulz F; Schöffling K
    Med Klin; 1973 Mar; 68(12):376-85. PubMed ID: 4806346
    [No Abstract]   [Full Text] [Related]  

  • 64. [Multicentric clinical proof of a new oral antidiabetic glisoxepide (BS 4231). 1. Establishment of proof and methods].
    Lehnert J; Kiesselbach NH; Blumenbach L
    Arzneimittelforschung; 1974 Mar; 24(0):433-7. PubMed ID: 4603693
    [No Abstract]   [Full Text] [Related]  

  • 65. Oral agents and the elderly diabetic.
    Skillman TG
    Geriatrics; 1979 Dec; 34(12):41-6. PubMed ID: 499816
    [No Abstract]   [Full Text] [Related]  

  • 66. Insulin and oral hypoglycemic agents.
    Price MJ
    Nurs Clin North Am; 1983 Dec; 18(4):687-706. PubMed ID: 6359069
    [No Abstract]   [Full Text] [Related]  

  • 67. [Treatment of diabetes mellitus with a mixture of oral hypoglycemic agents].
    Quibrera R; Nava M; Grimaldo JI
    Gac Med Mex; 1979 Mar; 115(3):121-6. PubMed ID: 378748
    [No Abstract]   [Full Text] [Related]  

  • 68. The oral hypoglycaemic agents reassess.
    Drug Ther Bull; 1974 Mar; 12(5):17-20. PubMed ID: 4820614
    [No Abstract]   [Full Text] [Related]  

  • 69. Rational choice of oral antihyperglycaemic agents.
    Chowdhury S; Sengupta N
    J Indian Med Assoc; 2002 Mar; 100(3):174-5, 177. PubMed ID: 12408278
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Therapeutic value of a new hypoglycemic agent (gliclazide) in the treatment of diabetes mellitus].
    Polosa P; Mughini L
    Clin Ter; 1978 Jan; 84(2):135-40. PubMed ID: 648096
    [No Abstract]   [Full Text] [Related]  

  • 71. A clinical trial of glibornuride in maturity-onset diabetes mellitus.
    Tandhanand S; Vannasaeng S; Aswapokee N; Soongsavang V; Aphonsuvan S
    J Med Assoc Thai; 1974 May; 57(5):232-6. PubMed ID: 4832761
    [No Abstract]   [Full Text] [Related]  

  • 72. Treatment with glibenclamide in maturity-onset diabetes mellitus.
    Persson I; Madsen SN
    Geriatrics; 1971 May; 26(5):182-95. PubMed ID: 5004113
    [No Abstract]   [Full Text] [Related]  

  • 73. Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancer.
    Prescrire Int; 2009 Jun; 18(101):115. PubMed ID: 19637427
    [No Abstract]   [Full Text] [Related]  

  • 74. [Treatment of diabetes mellitus with glibornurid].
    Vignati E; Liuzzi A; Chiodini PG
    Minerva Med; 1973 Oct; 64(75):3900-6. PubMed ID: 4767761
    [No Abstract]   [Full Text] [Related]  

  • 75. [Use of oral hypoglycemic agents in diabetic children].
    Otto-Buczkowska E
    Pol Tyg Lek; 1973; 28(24):904-7. PubMed ID: 4724902
    [No Abstract]   [Full Text] [Related]  

  • 76. Oral hypoglycemic agents.
    Forbath N
    Prim Care; 1977 Dec; 4(4):629-36. PubMed ID: 337336
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Clinical comparison between glibornuride (Glutril) and tolbutamide in senile diabetes. A controlled doblle-blind trial].
    Lindbjerg IF; Christoffersen EM; Kuusisto A; Lodahl K; Saglid U; Sterling N; Mikkelsen BO
    Ugeskr Laeger; 1976 Jun; 138(26):1572-4. PubMed ID: 133485
    [No Abstract]   [Full Text] [Related]  

  • 78. [Clinical comparison between glibornuride (Glutril) and glibenclamide in senile diabetes. A controlled double-blind trial].
    Mogensen EF; Worm J; Mikkelsen BO
    Ugeskr Laeger; 1976 Jun; 138(26):1569-71. PubMed ID: 133484
    [No Abstract]   [Full Text] [Related]  

  • 79. [Our experience with Daonil. A new oral hypoglycemic agent].
    Rodriguez-Miñon JL; Arrieta F; Herrera JL
    Diabete; 1970; 18(3):164-5. PubMed ID: 5472233
    [No Abstract]   [Full Text] [Related]  

  • 80. [Oral antidiabetic monotherapy and combination treatment with glybenclamide (HB 419) and biguanides of insulin receiving diabetics of the adult type].
    Knick B; Wendt O; Konder ML; Netter P
    Med Klin; 1970 Jan; 65(3):109-12. PubMed ID: 5519048
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.